NO943664L - Protein-cis-elementer fra en olje som regulerende signaler - Google Patents

Protein-cis-elementer fra en olje som regulerende signaler

Info

Publication number
NO943664L
NO943664L NO943664A NO943664A NO943664L NO 943664 L NO943664 L NO 943664L NO 943664 A NO943664 A NO 943664A NO 943664 A NO943664 A NO 943664A NO 943664 L NO943664 L NO 943664L
Authority
NO
Norway
Prior art keywords
pct
protein
oil
regulatory signals
cis elements
Prior art date
Application number
NO943664A
Other languages
English (en)
Other versions
NO321501B1 (no
NO943664D0 (no
Inventor
Maurice M Moloney
Original Assignee
Univ Technologies Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA1992/000161 external-priority patent/WO1993021320A1/en
Priority claimed from PCT/CA1993/000141 external-priority patent/WO1993020216A1/en
Application filed by Univ Technologies Int filed Critical Univ Technologies Int
Publication of NO943664D0 publication Critical patent/NO943664D0/no
Publication of NO943664L publication Critical patent/NO943664L/no
Publication of NO321501B1 publication Critical patent/NO321501B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/823—Reproductive tissue-specific promoters
    • C12N15/8234—Seed-specific, e.g. embryo, endosperm
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Peptides Or Proteins (AREA)
  • Fats And Perfumes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
NO19943664A 1992-04-02 1994-09-30 Fremgangsmate for a uttrykke en DNA-sekvens i en frocelle og for a endre frospesifikk metabolisme, samt DNA-konstruksjon, ekspresjonskassett, isolert transkripsjonsregulerende omrade, plante, fro og isolert DNA. NO321501B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86235592A 1992-04-02 1992-04-02
PCT/CA1992/000161 WO1993021320A1 (en) 1991-02-22 1992-04-15 Oil-body proteins as carriers of high-value peptides in plants
PCT/CA1993/000141 WO1993020216A1 (en) 1991-02-22 1993-04-02 Oil-body protein cis-elements as regulatory signals

Publications (3)

Publication Number Publication Date
NO943664D0 NO943664D0 (no) 1994-09-30
NO943664L true NO943664L (no) 1994-11-15
NO321501B1 NO321501B1 (no) 2006-05-15

Family

ID=25683013

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19943664A NO321501B1 (no) 1992-04-02 1994-09-30 Fremgangsmate for a uttrykke en DNA-sekvens i en frocelle og for a endre frospesifikk metabolisme, samt DNA-konstruksjon, ekspresjonskassett, isolert transkripsjonsregulerende omrade, plante, fro og isolert DNA.

Country Status (12)

Country Link
US (1) US5792922A (no)
EP (1) EP0633940B1 (no)
JP (1) JP3660354B2 (no)
KR (1) KR100278456B1 (no)
AT (1) ATE229076T1 (no)
AU (1) AU678154B2 (no)
DE (1) DE69332538T2 (no)
ES (1) ES2187505T3 (no)
FI (1) FI120314B (no)
NO (1) NO321501B1 (no)
RU (1) RU2148647C1 (no)
UA (1) UA41319C2 (no)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586661B1 (en) 1997-06-12 2003-07-01 North Carolina State University Regulation of quinolate phosphoribosyl transferase expression by transformation with a tobacco quinolate phosphoribosyl transferase nucleic acid
US6635806B1 (en) * 1998-05-14 2003-10-21 Dekalb Genetics Corporation Methods and compositions for expression of transgenes in plants
DE19923571A1 (de) * 1999-05-21 2000-11-23 Kws Saat Ag Nukleotid-Sequenz zur Erhöhung der Abwehrreaktion einer Pflanze gegen Pathogenbefall
US20030140372A1 (en) * 1999-06-07 2003-07-24 Shen Jennie Bih-Jien Genes for desaturases to alter lipid profiles in corn
US6784342B1 (en) 1999-08-04 2004-08-31 The University Of British Columbia Regulation of embryonic transcription in plants
RU2164944C1 (ru) * 1999-12-09 2001-04-10 Институт молекулярной биологии им. В.А. Энгельгардта РАН Способ изменения генетических свойств организма
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
CA2420325A1 (en) 2000-08-25 2002-02-28 Basf Plant Science Gmbh Plant polynucleotides encoding novel prenyl proteases
CN1330753C (zh) * 2000-08-30 2007-08-08 北卡罗莱纳州立大学 含有可改变蛋白含量的分子诱导物的转基因植物
US20030167524A1 (en) * 2000-12-19 2003-09-04 Rooijen Gijs Van Methods for the production of multimeric protein complexes, and related compositions
BR0116220A (pt) * 2000-12-19 2003-09-23 Sembiosys Genetics Inc Métodos para a produção de proteìnas multiméricas e composições relacionadas
BR0209181A (pt) 2001-04-24 2004-08-24 Cornell Res Foundation Inc Molécula sintética de ácido nucléico para conferir traços múltiplos
US20050287647A9 (en) * 2001-05-30 2005-12-29 Carl Perez Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
US20060179514A1 (en) * 2001-07-05 2006-08-10 Sembiosys Genetics, Inc. Methods for the production of multimeric protein complexes, and related compositions
EP2042196B1 (en) 2001-10-10 2016-07-13 ratiopharm GmbH Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
US7329798B2 (en) * 2002-06-28 2008-02-12 University Of Guelph Harvest-inducible regulatory elements and methods of using same
WO2004002216A2 (en) 2002-06-28 2004-01-08 University Of Guelph Harvest-inducible genes from alfalfa (medicago sativa) and methods of use thereof
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
EP1594955B1 (en) 2003-02-14 2012-04-11 Biogen Idec MA Inc. An expression cassette and vector for transient or stable expression of exogenous molecules
NZ542586A (en) 2003-04-09 2009-11-27 Biogenerix Ag Method of forming a covalent conjugate between a G-CSF peptide and PEG
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
ATE405660T1 (de) 2003-06-17 2008-09-15 Sembiosys Genetics Inc Verfahren zur insulinproduktion in pflanzen
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
WO2005041151A2 (en) * 2003-10-02 2005-05-06 Vector Tobacco Ltd. Tobacco product labeling system
WO2006007432A2 (en) * 2004-06-16 2006-01-19 Basf Plant Science Gmbh Nucleic acid molecules encoding wrinkled1-like polypeptides and methods of use in plants
AU2006298442A1 (en) 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
AR053477A1 (es) 2005-05-23 2007-05-09 Arcadia Biosciences Inc Cartamo con acido gamma - linolenico elevado
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090049569A1 (en) * 2007-08-13 2009-02-19 Pioneer Hi-Bred International, Inc. Seed-Preferred Regulatory Elements
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
JP5499408B2 (ja) * 2008-05-28 2014-05-21 国立大学法人京都大学 新規選択マーカー遺伝子およびその利用
CA3020943A1 (en) 2009-04-22 2010-10-28 Basf Plant Science Company Gmbh Whole seed specific promoter
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
EP2482788B1 (en) 2009-10-02 2022-12-14 Journey Medical Corporation Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
AU2015258019B2 (en) 2014-05-06 2017-02-23 Unilever Ip Holdings B.V. Composition in the form of an oil-in-water emulsion comprising ground white or yellow mustard seed
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
WO2026027990A1 (en) 2024-07-30 2026-02-05 Core Biogenesis Sas Bioactive growth factors for dermal topical applications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221259A (en) * 1986-07-31 1990-05-28 Calgene Inc Seed specific transcriptional regulation
US5500361A (en) * 1991-11-15 1996-03-19 E. I. Du Pont De Nemours And Company β-ketoacyl-ACP synthetase II genes from plants

Also Published As

Publication number Publication date
FI944550L (fi) 1994-11-30
NO321501B1 (no) 2006-05-15
JPH07505525A (ja) 1995-06-22
AU3884493A (en) 1993-11-08
JP3660354B2 (ja) 2005-06-15
RU94046161A (ru) 1997-05-10
ATE229076T1 (de) 2002-12-15
KR950700995A (ko) 1995-02-20
US5792922A (en) 1998-08-11
EP0633940B1 (en) 2002-12-04
KR100278456B1 (ko) 2001-01-15
AU678154B2 (en) 1997-05-22
EP0633940A1 (en) 1995-01-18
ES2187505T3 (es) 2003-06-16
DE69332538T2 (de) 2003-11-06
UA41319C2 (uk) 2001-09-17
NO943664D0 (no) 1994-09-30
FI120314B (fi) 2009-09-15
RU2148647C1 (ru) 2000-05-10
DE69332538D1 (de) 2003-01-16
FI944550A0 (fi) 1994-09-30

Similar Documents

Publication Publication Date Title
NO943664D0 (no) Protein-cis-elementer fra en olje som regulerende signaler
Zhu et al. Regulation of the lmo2 promoter during hematopoietic and vascular development in zebrafish
NO930011D0 (no) Tilfeldig boi-oligomer bibilotek og fremgangsmaate for syntese og anvendelse derav
Shibanuma et al. Release of H2O2 and phosphorylation of 30 kilodalton proteins as early responses of cell cycle-dependent inhibition of DNA synthesis by transforming growth factor beta 1
EA200000109A1 (ru) Химерный белок растворимого рецептора интерлейкина-6/лиганда, его аналоги и способы применения
ES2083595T3 (es) Derivados de indol que inhiben la biosintesis de leucotrienos.
EA200000926A1 (ru) Экспрессия генов биосинтеза трегалозы в растениях
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
DE69837337D1 (de) Herstellung von proteinen in eiern
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
DE69225410D1 (de) Herstellung von n-acetylneuraminsäure-derivaten
KR950700234A (ko) β-페닐이소세린 및 그외 동족체를 제조하는 방법(Method for preparing β-phenylisoserine and analogues thereof)
DE69729730D1 (de) Transgene mäuse, die den leukämie inhibierungsfaktor exprimieren können
ATE271394T1 (de) Hybride zusammensetzungen für intrazellulaire verabreichung
ATE309270T1 (de) ßSMOOTHENEDß PROTEINE AUS WIRBELTIEREN
FR2703054B1 (fr) Promoteur vegetal inductible au stress et cellules vegetales contenant une unite d'expression d'une proteine d'interet comprenant ledit promoteur.
Oda‐Ishii et al. Lineage‐independent mosaic expression and regulation of the Ciona multidom gene in the ancestral notochord
Shostak Inhibitory gradients of head and foot regeneration in Hydra viridis
AR013801A1 (es) Nuevas moleculas de acido nucleico aislada, una proteina de epoxido hidrolasa de artropodo hematofago aislada, una formulacion de proteinas deepoxido hidrolasa de pulga, una composicion terapeutica que reduce la infestacion de ectoparasitos hematofagos; uso de dicha composicion para la
DE69929683D1 (de) Antisense modulierung von lfa-3
ATE294189T1 (de) Kristallisation von proteinen
DK0651811T3 (da) Promotor fra ribosomproteingenet RP28 af K. Lactis og anvendelse deraf
DE59809344D1 (de) Disubstituierte biphenyloxazoline
Yang et al. Cooperative ETS transcription factors are required for lymphatic endothelial cell integrity and resilience
Palermo Transgenic approaches to understanding myosin structure and function

Legal Events

Date Code Title Description
MK1K Patent expired